Command Palette

Search for a command to run...

SPARC

134.15+0.10%
Market Cap
₹4,343.72 Cr
Stock P/E
-14.55
ROCE
-311.92%
ROE
0.00%
Book Value
₹-8.28

Financials

YoY Net Sales
EPS Growth
Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Broad-Based Selling

Sun Pharma Advanced Research Company Ltd. (SPARC) exhibits several red flags in its financial metrics, including negative earnings and poor returns on equity. In contrast, Syngene International Ltd. stands out as a sector leader with solid profitability and growth metrics, while other companies like Just Dial Ltd. and CMS Info Systems Ltd. offer attractive valuation metrics, positioning them as potential value picks amidst the broader market weakness.

Key Points
  • SPARC shows negative EPS and ROE, indicating financial distress.
  • Syngene International leads in profitability metrics, with a PE ratio of 54.67 but high growth rates.
  • Just Dial and CMS Info Systems have low PE ratios, making them attractive value picks despite varying profitability.
  • Sagility India and Latent View Analytics show high PE ratios, indicating potential overvaluation.
Top Performers
Syngene International Ltd.

Highest profitability metrics with solid revenue growth and efficient operations.

Just Dial Ltd.

Attractive valuation (low PE) with significant EPS growth potential.

CMS Info Systems Ltd.

Strong profitability with low debt and reasonable valuation metrics.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.